4.8 Article

Bladder Cancer in 2010 How Far Have We Come?

Journal

CA-A CANCER JOURNAL FOR CLINICIANS
Volume 60, Issue 4, Pages 244-272

Publisher

WILEY
DOI: 10.3322/caac.20077

Keywords

-

Categories

Funding

  1. Pfizer

Ask authors/readers for more resources

Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high-risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010;60:244-272. (C) 2010 American Cancer Society, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available